Accumulating evidence suggested that FXR can be an effective target to alleviate the pathogenesis of various liver diseases, including primary biliary cholangitis, nonalcoholic fatty liver disease, and liver fibrosis [31]. This evidence concerns the gene NR1H4 and biliary liver cirrhosis.